Crossfund Sicav-Cross.Healthcare Fd.B/ LU1334634612 /
NAV01/10/2024 | Chg.-0.7100 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
166.8600USD | -0.42% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | 0.70 | 0.32 | 0.24 | 4.62 | -1.02 | 2.44 | 3.12 | 1.82 | -4.64 | 3.87 | -4.22 | 5.90 | +13.33% |
2022 | -7.86 | -1.49 | 4.11 | -5.45 | -0.11 | -2.12 | 2.23 | -5.77 | -2.81 | 8.28 | 2.52 | -0.03 | -9.24% |
2023 | -2.04 | -3.09 | 1.72 | 3.71 | -3.98 | 3.52 | -0.18 | -1.16 | -2.90 | -5.85 | 4.33 | 6.04 | -0.64% |
2024 | 3.07 | 2.48 | 2.57 | -4.67 | 2.28 | 2.59 | 1.33 | 4.67 | -3.60 | -0.42 | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 10.50% | 10.85% | 11.05% | 12.70% | -% |
Sharpe ratio | 1.03 | 0.46 | 1.13 | -0.13 | - |
Best month | +6.04% | +4.67% | +6.04% | +8.28% | - |
Worst month | -4.67% | -4.67% | -5.85% | -7.86% | - |
Maximum loss | -6.44% | -4.44% | -7.85% | -19.83% | - |
Outperformance | - | - | - | - | - |
All quotes in USD
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Crossfund Sicav-Cross.Healthcare... | reinvestment | 136.9600 | +11.23% | -4.72% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 145.1000 | +14.02% | -0.70% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 171.6500 | +16.05% | +5.94% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 133.6800 | +10.81% | -5.81% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 166.8600 | +15.68% | +4.79% | |
CROSSFUND SICAV - Crossinvest He... | reinvestment | 141.4800 | +13.57% | -1.87% |
Performance
YTD | +10.34% | ||
---|---|---|---|
6 Months | +4.04% | ||
1 Year | +15.68% | ||
3 Years | +4.79% | ||
5 Years | - | ||
10 Years | - | ||
Since start | +13.06% | ||
Year | |||
2023 | -0.64% | ||
2022 | -9.24% | ||
2021 | +13.33% |